It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from ...

A mix of domestic revenue generation, efficiency gains and strategic partnerships is essential to sustain and expand HIV ...

WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.

Gilead Sciences, Inc. GILD announced that the investigational single-tablet regimen of bictegravir and lenacapavir for the treatment of HIV met the primary endpoint in the late-stage ARTISTRY-2 study.

In case you've faced some hurdles solving the clue, HIV-prevention drug, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test ...

People infected with HIV must take antiretroviral drugs for life. But promising trials using engineered antibodies suggest that "functional cures" may be in reach. When you purchase through links on ...

The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, to the African nations of Eswatini and Zambia, the U.S. State Department ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease. Integrase strand ...

WASHINGTON, Nov 18 (Reuters) - About 1,000 doses of Gilead Sciences Inc's (GILD.O), opens new tab drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and company officials said, ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by ...